BioCentury
ARTICLE | Clinical News

O-Vax: Phase I/II started

April 14, 2008 7:00 AM UTC

Avax began a U.S. Phase I/II trial to evaluate three dose strengths of O-Vax in 42 post-surgical patients following taxane-based chemotherapy. ...